pantoprazole and lansoprazole

pantoprazole has been researched along with lansoprazole in 210 studies

Research

Studies (210)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's41 (19.52)18.2507
2000's101 (48.10)29.6817
2010's54 (25.71)24.3611
2020's14 (6.67)2.80

Authors

AuthorsStudies
Figala, V; Klemm, K; Kohl, B; Krüger, U; Rainer, G; Schaefer, H; Senn-Bilfinger, J; Simon, WA; Sturm, E1
Nakamura, K; Nishikawa, Y; Seto, Y; Tada, K; Tanitame, A; Terauchi, H1
Fromm, MF; Klotz, U; Pauli-Magnus, C; Rekersbrink, S1
Bariwal, J; Bhosale, AV; Jagtap, JR; Jain, KS; Kale, AP; Shah, AK; Shelke, SM1
Andricopulo, AD; Moda, TL; Montanari, CA1
Lombardo, F; Obach, RS; Waters, NJ1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ1
Castillo, R; Hernández-Campos, A; Hernández-Luis, F; Pérez-Villanueva, J; Romo-Mancillas, A; Yépez-Mulia, L1
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR1
Bakmiwewa, SM; Ball, HJ; Fatokun, AA; Hunt, NH; Payne, RJ; Tran, A1
Dalvie, D; Loi, CM; Smith, DA1
Fako, VE; Liu, JY; Pflug, B; Wu, X; Zhang, JT1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Bala, V; Chhonker, YS1
Beghyn, T; Bosc, D; Charton, J; Deprez, B; Deprez-Poulain, R; Guillaume, V; Herledan, A; Hermant, P; Landry, V; Leroux, F; Liang, W; Pottiez, V; Sheng, L; Tang, WJ; Urata, S; Warenghem, S1
Delabio, LC; Dutra, JP; Hembecker, M; Kita, DH; Moure, VR; Pereira, GDS; Scheiffer, G; Valdameri, G; Zattoni, IF1
Büdingen, C; Fahr, S; Kinder, B; Koske, M; Simon, WA1
Dítĕ, P; Prásek, J1
Creutzfeldt, W2
Tucker, GT1
Arnold, R1
Kromer, W2
Kaplan, B; Mears, JM1
Huber, R; Kolassa, N; Radtke, HW; Steinijans, VW; Zech, K1
Andersson, T1
Meyer, UA1
Leonhardt, U; Ramadori, G; Ritzel, U1
Hildebrandt, AG; Kleeberg, U; Krusekopf, S; Ruckpaul, K1
Eberle, D; Hummel, RP; Kuhn, R1
Florent, C; Forestier, S1
Andersson, T; Unge, P1
Berstad, A; Hatlebakk, JG1
Hakusui, H; Masubuchi, N; Okazaki, O2
Bateman, DN1
Besancon, M; Sachs, G; Shin, JM; Simon, A1
Masubuchi, N; Okazaki, O1
Andersson, K; Bayati, A; Lee, H; Lorentzon, P1
Chiocca, JC; Salis, GB1
Malfertheiner, P; Nakao, M1
Andersson, T; Holmberg, J; Röhss, K; Walan, A1
Hetzel, D1
Lambert, JR; Treiber, G1
Diehl, KL; Geyer, P; Jaspersen, D; Martens, E; Schoeppner, H1
Li, AP; Masubuchi, N; Okazaki, O1
Gleiter, CH1
Zaigler, M1
Dattilo, M; Figura, N1
Kato, S; Konaka, A; Nishijima, M; Takeuchi, K; Yasuhiro, T1
Addolorato, G; Armuzzi, A; Cammarota, G; Cannizzaro, O; Cianci, R; Gasbarrini, A; Gasbarrini, GB; Papa, A1
Faure, C; Languepin, J; Pelatan, C1
Horbach, S; Kromer, W; Lühmann, R1
Dilger, K; Klotz, U; Zheng, Z1
Ekpe, A; Jacobsen, T1
Bustamante, M; Stollman, N1
Bong, JL; Douglas, WS; Lucke, TW1
Moustafa, AA1
Goldwater, DR; Hunt, RH; Pan, WJ; Pilmer, BL; Zhang, Y1
Malki, SA; Yeomans, ND1
Howden, CW1
Dunn, NR; Freemantle, S; Martin, RM; Shakir, S1
Botta, F; Chiarbonello, B; Fasoli, A; Giannini, E; Lantieri, PB; Malfatti, F; Risso, D; Romagnoli, P; Savarino, V; Testa, R1
Thomson, AB1
Anic, T; Aralica, G; Bilic, I; Buljat, G; Ivankovic, D; Mikus, D; Mise, S; Perovic, D; Petek, M; Prkacin, I; Rotkvic, I; Rucman, R; Seiwerth, S; Separovic, J; Sikiric, P; Stancic-Rokotov, D; Zoricic, I1
Athmann, C; Boldt, JH; Brunner, G1
Bradley, CP; Greenfield, SM; Jones, MI; Jowett, S; Seal, R1
Bardou, M1
Dupas, JL; Houcke, P; Samoyeau, R1
Gerson, LB; Triadafilopoulos, G1
Tytgat, GN1
Chiu, YL; Freston, J; Lukasik, N; Pan, WJ; Täubel, J1
Caro, JJ; Salas, M; Ward, A1
Herszényi, L; Tulassay, Z1
Chiu, YL; Lukasik, NL; Pan, WJ; Pilmer, BL; Sharma, VK; Täubel, JJ1
Barth, J; Hahne, W1
Appelman, SA; Chiu, YL; Goldwater, DR; Huang, JQ; Hunt, RH; James, CF; Keith, RG; Pilmer, BL; Sridhar, S; Thomson, AB1
Anderloni, A; Bianchi Porro, G; Imbesi, V; Maconi, G; Parente, F; Sainaghi, M; Sangaletti, O1
Bruni, AT; Ferreira, MM; Leite, VB1
Calvet, X; Gisbert, JP; Vallve, M; Vergara, M1
Mignon, M; Ramdani, A; Samoyeau, R1
de Groot, GH; Mulder, CJ; Otten, MH; Oudkerk Pool, M; Smit, JM; Tan, TG; van Milligen de Wit, AW; Westerveld, BD1
Tahboub, RM; Vanderhoff, BT1
Morozov, IA1
Abdel-Razak, O; Gazy, AA; Mahgoub, H; Moneeb, MS; Wahbi, AA1
Frissora, C; Katz, PO1
De Micheli, E; Frazzoni, M; Grisendi, A; Savarino, V1
Beckerling, A; Gatz, G; Ulmer, HJ1
Kleeberg, U; Krusekopf, S; Roots, I1
Koelz, HR; Labenz, J; Petersen, KU; Rösch, W2
Blum, AL; Dorta, G; Jornod, P; Pantoflickova, D; Ravic, M1
Hellström, PM; Vitols, S1
Balashova, NN; Busarova, GA; Maev, IV1
Chen, Y; Katz, PO; Miner, P; Sostek, M1
Castell, DO; Katz, PO; Tutuian, R; Xue, S1
Becker, TL; de Mendonça, S; Gambero, A; Maróstica, M; Pedrazzoli, J; Ribeiro, ML1
Aeed, H; Avni, Y; Boaz, M; Levine, A; Moss, SF; Niv, Y; Shabat-Sehayek, V; Shevah, O; Shirin, H1
Karaoglu, AO; Yasa, MH; Yukselen, V1
Ahlström, M; Andersson, TB; Li, XQ; Weidolf, L1
Barrientos-Astigarraga, RE; de Nucci, G; Mendes, GD; Oliveira, CH; Peres, O; Rezende, VM1
Lind, T; Röhss, K; Wilder-Smith, C1
Alonso, C; Bernal, JL; del Nozal, MJ; Jiménez, JJ; Toribio, L1
Hill, RK; Larson, N; Simpson, CB; Velazquez, R1
D'Ambrosio, LP; Franceschi, M; Leandro, G; Longoa, MG; Orsitto, G; Perri, FC; Pilotto, A; Scarcelli, C1
Hellström, PM1
Iinuma, K; Kato, S; Konno, M; Maisawa, S; Nakayama, Y; Shimizu, T; Tajiri, H; Toyoda, S; Yoshimura, N1
Katz, PO2
Arnon, J; Clementi, M; De Santis, M; Diav-Citrin, O; Malm, H; Ornoy, A; Robert-Gnansia, E; Schaefer, C; Shechtman, S; Valti, E; van Tonningen, MR1
Babic, Z; Lucijanic-Mlinac, M; Marusic, M; Nesanovic, M; Stajcar, V1
Barry, M; Bennett, K; McGowan, B; Tilson, L1
Brown, RE; Remák, E; Robinson, A; Yuen, C1
Ateş, Y; Bağci, S; Ciğerim, M; Dağalp, K; Kadayifçi, A; Karslioğlu, Y; Savaş, MC; Uygun, A; Yeşilova, Z1
Calvet, X; Gomollón, F1
Hartmann, HJ; Simon, WA; Sturm, E; Weser, U1
Baker, DE1
Amer, F; Hunt, B; Kukulka, MJ; Metz, DC; Samra, N; Vakily, M1
Avorn, J; Canning, C; Dormuth, CR; Glynn, RJ; Maclure, M; Schneeweiss, S1
Goldstein, JL; Liu, S; Miner, PB; Schlesinger, PK; Silberg, DG1
Gunaratnam, NT; Inadomi, J; Jessup, TP; Lascewski, DP1
El-Bardicy, MG; El-Sherif, ZA; El-Tarras, MF; Mohamed, AO1
Clark, DW; Strandell, J1
Bozkurt, B; Demirkan, K; Kalyoncu, AF; Karakaya, G1
Akyol, H; Barisik, NO; Bingul, S; Colak, E; Kaptanoglu, L; Kucuk, HF; Kurt, N; Torlak, OA1
El-Eswed, B; Qaisi, AM; Tutunji, LF; Tutunji, MF1
Edwards, SJ; Lind, T; Lundell, L1
Brørs, O1
Esplugues, JV; Martí-Cabrera, M; Ponce, J1
Andersson, S; Nelander, H; Ohlén, K1
Forrester, MB1
Molnar, B; Mullner, K; Tulassay, Z1
Boyer, K; Tolia, V1
Andriulli, A; Annese, V; D'Ambrosio, LP; Di Mario, F; Franceschi, M; Leandro, G; Paris, F; Pilotto, A; Scarcelli, C; Seripa, D1
Bygum, A; Dam, C1
Franck, PF; Geus, WP; Hunfeld, NG; Kuipers, EJ; Mathot, RA; Mulder, PG; Touw, DJ; van Schaik, RH1
Pérez-Manauta, J1
Alonso, C; Bernal, YL; del Nozal, MJ; Jiménez, JJ; Toribio, L1
Andersson, T; Weidolf, L1
Brugnera, R; Calabrese, C; Di Febo, G; Gabusi, V; Gionchetti, P; Liguori, G; Rizzello, F; Straforini, G1
Charlemagne, A; Fagnani, F; Le Jeunne, P; Mouly, S1
Naseri, E; Yenişehirli, A1
Bagin, RG; Ballard, ED; Gautille, TC; Howden, CW; Koch, FK1
Cho, YK; Choi, WH; Hong, CH; Hong, EJ; Jeon, WK; Kim, BI; Kim, HJ; Oh, SJ; Park, DI; Park, JH; Shon, CI; Song, MJ1
Zheng, RN1
Pellicano, R1
Bharathi, DV; Chatki, PK; Hotha, KK; Jagadeesh, B; Mullangi, R; Naidu, A; Thriveni, K1
Furuta, T; Hishida, A; Ikuma, M; Kodaira, C; Nishino, M; Sugimoto, M; Umemura, K; Watanabe, H; Yamade, M1
Bretagne, JF1
Hunt, RH; Padol, S; Yaghoobi, M; Yuan, Y1
Barker, PN; Goldstein, JL; Illueca, M; Katz, PO; Morgan, D; Pandolfino, J1
Keyhanfar, F; Mahmoudian, M; Motevalian, M; Noubarani, M1
Hunt, R; Sachs, G; Shin, JM1
Barreiro, JC; Cass, QB; Vanzolini, KL1
Benninga, MA; Omari, TI; Smits, MJ; Tabbers, MM; van der Pol, RJ; van Wijk, MP1
Buckley, DB; Kazmi, F; Ogilvie, BW; Paris, BL; Parkinson, A; Rostami-Hodjegan, A; Toren, P; Yerino, P1
Buyukafsar, K; Erenmemisoglu, A; Ozkur, M; Pektas, M; Un, I; Yurtsever, AS1
Eberlein, B; Gebhardt, E; Gilbertz, KP; Placzek, M; Przybilla, B1
Gao, J; Gao, S; Gong, YF; Guo, XR; Li, Z; Li, ZS; Liao, Z; Liu, P; Zhan, XB1
Bernasconi, GC; Cass, QB; Cassiano, NM; Oliveira, RV1
Chang, SY; Chen, C; Chimalakonda, A; Hurley, J; Rodrigues, AD; Thorndike, D; Vuppugalla, R; Wagner, A; Yang, Z; Zvyaga, T1
Chularojanamontri, L; Dhana, N; Jiamton, S; Jongjarearnprasert, K; Kulthanan, K; Manapajon, A; Suvanasuthi, S1
Banahan, BF; Bentley, JP; Datar, MV; Mahabaleshwarkar, RK; Null, KD; Strum, MW; Yang, Y1
Baker, RD; Baker, SS; Burlingame, AL; Egilmez, NK; Forte, JG; Liu, W; Trinidad, J; Virtuoso, LP; Zhu, L1
Bhushan, R; Dixit, S; Dubey, R1
Hatlebakk, JG; Jonasson, C; Tvete, IF1
Forte, JG; Guan, S; Machen, TE; Watson, C; Zhu, L1
Afonso, C; Rajab, A; Rudler, H; Seuleiman, M; Touma, M1
Angioli, R; Damiani, P; Improta, G; Petrella, C; Plotti, F; Scarpignato, C; Severini, C; Signore, F; Terranova, C1
Cao, Z; Kang, T; Tian, C; Yu, D; Zhu, L; Zhu, R1
Kim, EH; Kim, HY; Lee, SK; Park, CH; Roh, YH1
Bilker, WB; Brensinger, CM; Flockhart, DA; Freeman, CP; Hennessy, S; Kasner, SE; Kimmel, SE; Leonard, CE1
Hauser, G; JajacKnez, A; Salkic, N; Stimac, D; Vukelic, K1
Akers, KS; Boyd, NK; Niece, KL1
Benjak, A; Busso, P; Cole, ST; Pojer, F; Rybniker, J; Sala, C; Vocat, A1
Saniee, P; Shahreza, S; Siavoshi, F1
Accassat, S; Basset, T; Bertoletti, L; Delavenne, X; Hodin, S; Mismetti, P; Ollier, E1
Abbas, MG; Akter, N; Akter, S; Bhuiyan, MA; Hassan, MR; Shahriar, M1
Andabak, M; Babic, Z; Banic, M; Bilić, B; Bogdanovic, Z; Dorosulic, Z; Heinzl, R; Kujundzic, M; Marusic, M; Petrovic, Z1
Jang, BI; Jung, YS; Kim, KO; Kim, TN; Lee, SH1
Christensen, RD; Haastrup, PF; Hansen, JM; Jarbøl, DE; Paulsen, MS; Søndergaard, J1
Chen, MH; Chu, CJ; Hou, MC; Huang, YH; Lee, FY; Lin, HC; Lu, CL; Su, TP; Tsai, CF; Wang, YP1
Aydın, D; Çelebi, A; Hülagü, S; Kocaman, O; Konduk, BT; Şentürk, Ö1
Li, MJ; Li, Q; Liu, LQ; Sun, M1
Bhaskaran, K; Douglas, IJ; Langan, S; Smeeth, L; Thomas, S; Tomlinson, LA; Yates, TA1
Argyropoulos, T; Briki, A; Chatzidakis, G; Kpogho, I; Malliou, P; Poulou, A; Ravanis, G; Sgourakis, G; Stankovičová, T; Tsuruhara, H; Vagia, A1
Chen, D; Fei, G; Lu, B; Wang, B; Wang, J; Wang, X; Wu, B; Zhang, L; Zou, D; Zou, X1
Calissendorff, J; Falhammar, H; Lindh, JD; Mannheimer, B; Nathanson, D; Skov, J1
Kan, LD; Li, LC; Wu, CY; Ying, J; Yu, ZW1
Jiao, HW; Li, YQ; Liu, Y; Shen, YW; Sun, LN; Wang, MF; Wang, YQ; Xie, LJ; Xu, YH; Yu, L; Zhang, HW; Zhang, XH1
Karimova, MM; Makarenko, OV; Masheiko, AM; Onul, NM1
Foroumadi, A; Kadkhodaei, S; Kolahdoozan, S; Sarrafnejad, A; Siavoshi, F1
Abu-Rish, EY; Dahabiyeh, LA; Taha, MO1
Ding, H; Hu, L; Huang, Q; Jiang, Y; Liu, Q; Liu, S; Yin, T1
Abed, MN; Alassaf, FA; Alfahad, M; Jasim, MHM; Qazzaz, ME1
Huang, X; Liu, Y; Shen, Y; Su, YW; Sun, LN; Wang, YQ; Yang, YQ; Ying, YW; Zhang, XH; Zhang, Y1
Arnaud, B; Arnoult, C; Escoffier, J; Hograindleur, JP; Kaba, M; Le Blévec, E; Martinez, G; Nef, S; Ray, PF; Stévant, I1
Abramenko, N; Antonyová, V; Brogyányi, T; Dytrych, P; Ikeda-Saito, M; Jakubek, M; Kaplánek, R; Kejík, Z; Martásek, P; Pajková, M; Sýkora, D; Tatar, A; Veselá, K1
Chen, F; Fang, B; He, X; Wang, S1
Latifah, N; Ramadhani, M1
Chan, AT; Choi, HK; Lei, G; Lu, N; Misra, D; Neogi, T; Wei, J; Zeng, C; Zhang, Y1
Chen, Y; Hou, Y; Li, H; Li, S; Lin, J; Liu, T; Ma, Y; Wang, Y; Yang, H; Zhang, X; Zhang, Y; Zhou, L; Zhou, X1
Lespessailles, E; Toumi, H1
Chen, X; Jiang, H; Lu, S; Ma, Z; Xu, S; Yang, X; Zhang, Y; Zhao, J; Zhou, H1

Reviews

53 review(s) available for pantoprazole and lansoprazole

ArticleYear
Recent advances in proton pump inhibitors and management of acid-peptic disorders.
    Bioorganic & medicinal chemistry, 2007, Feb-01, Volume: 15, Issue:3

    Topics: Animals; Anti-Ulcer Agents; Gastric Acid; Gastroesophageal Reflux; Helicobacter Infections; Humans; Peptic Ulcer; Proton Pump Inhibitors

2007
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Recent developments in anti-Trichomonas research: An update review.
    European journal of medicinal chemistry, 2018, Jan-01, Volume: 143

    Topics: Antiparasitic Agents; Biological Products; Dose-Response Relationship, Drug; Humans; Molecular Structure; Parasitic Sensitivity Tests; Structure-Activity Relationship; Trichomonas; Trichomonas Infections

2018
Targeting breast cancer resistance protein (BCRP/ABCG2): Functional inhibitors and expression modulators.
    European journal of medicinal chemistry, 2022, Jul-05, Volume: 237

    Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Breast Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Neoplasm Proteins; Neoplastic Stem Cells

2022
[Proton pump blockers and their significance in gastroenterology].
    Vnitrni lekarstvi, 1995, Volume: 41, Issue:8

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Esophagitis, Peptic; Gastrointestinal Diseases; Humans; Lansoprazole; Omeprazole; Pantoprazole; Peptic Ulcer; Proton Pump Inhibitors; Sulfoxides; Zollinger-Ellison Syndrome

1995
[Are proton pump inhibitors safe?].
    Der Internist, 1994, Volume: 35, Issue:12

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Benzimidazoles; Carcinogenicity Tests; Gastric Acid; Humans; Lansoprazole; Mutagenicity Tests; Omeprazole; Pantoprazole; Parietal Cells, Gastric; Peptic Ulcer; Prodrugs; Proton Pump Inhibitors; Structure-Activity Relationship; Sulfoxides

1994
The interaction of proton pump inhibitors with cytochromes P450.
    Alimentary pharmacology & therapeutics, 1994, Volume: 8 Suppl 1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Benzimidazoles; Cytochrome P-450 Enzyme System; Half-Life; Humans; Lansoprazole; Microsomes, Liver; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides

1994
Safety of proton pump inhibitors--an overview.
    Alimentary pharmacology & therapeutics, 1994, Volume: 8 Suppl 1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Benzimidazoles; Cytochrome P-450 Enzyme System; Disease Models, Animal; Drug Interactions; Enterochromaffin Cells; Gastrins; Humans; Lansoprazole; Omeprazole; Pantoprazole; Peptic Ulcer; Proton Pump Inhibitors; Sulfoxides

1994
Similarities and differences in the properties of substituted benzimidazoles: a comparison between pantoprazole and related compounds.
    Digestion, 1995, Volume: 56, Issue:6

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Cytochrome P-450 Enzyme Inhibitors; Gastric Acid; Humans; Lansoprazole; Omeprazole; Pantoprazole; Sulfoxides

1995
Proton pump inhibitors: new drugs and indications.
    American family physician, 1996, Volume: 53, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Enzyme Inhibitors; Humans; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Proton Pumps; Sulfoxides

1996
Pharmacokinetics and drug interactions--relevant factors for the choice of a drug.
    International journal of clinical pharmacology and therapeutics, 1996, Volume: 34, Issue:1 Suppl

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Benzimidazoles; Drug Interactions; Enzyme Inhibitors; Humans; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides

1996
Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole.
    Clinical pharmacokinetics, 1996, Volume: 31, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Humans; Lansoprazole; Liver; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides

1996
Drug interactions with proton pump inhibitors.
    Drug safety, 1997, Volume: 16, Issue:3

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Humans; Lansoprazole; Mixed Function Oxygenases; Omeprazole; Pantoprazole; Sulfoxides

1997
Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
    Clinical pharmacokinetics, 1996, Volume: 31, Issue:5

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Antacids; Benzimidazoles; Cimetidine; Cisapride; Domperidone; Famotidine; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Lansoprazole; Metoclopramide; Nizatidine; Omeprazole; Pantoprazole; Piperidines; Proton Pump Inhibitors; Ranitidine; Sucralfate; Sulfoxides

1996
[Gastroesophageal reflux disease refractory to medical treatment. Which approach: the pill or the scalpel?].
    Acta gastroenterologica Latinoamericana, 1997, Volume: 27, Issue:3

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Fundoplication; Gastroesophageal Reflux; Humans; Lansoprazole; Laparoscopy; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Recurrence; Sulfoxides

1997
Acid pump inhibitors. The treatment of gastroesophageal reflux.
    Australian family physician, 1998, Volume: 27, Issue:6

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Cisapride; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Lansoprazole; Omeprazole; Pantoprazole; Piperidines; Ranitidine; Sulfoxides

1998
The impact of Helicobacter pylori eradication on peptic ulcer healing.
    The American journal of gastroenterology, 1998, Volume: 93, Issue:7

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Antacids; Anti-Ulcer Agents; Benzimidazoles; Duodenal Ulcer; Gastric Acid; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Odds Ratio; Omeprazole; Pantoprazole; Peptic Ulcer; Ranitidine; Stomach Ulcer; Sulfoxides; Treatment Outcome; Wound Healing

1998
Helicobacter pylori infection, chronic gastritis, and proton pump inhibitors.
    Journal of clinical gastroenterology, 1998, Volume: 27 Suppl 1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Chronic Disease; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides

1998
[Proton pump inhibitors in pediatrics].
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 1999, Volume: 6, Issue:6

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Benzimidazoles; Child; Enzyme Inhibitors; Humans; Lansoprazole; Omeprazole; Pantoprazole; Peptic Ulcer; Proton Pump Inhibitors; Proton-Translocating ATPases; Sulfoxides

1999
Relative efficacies of gastric proton pump inhibitors: their clinical and pharmacological basis.
    Pharmacology, 1999, Volume: 59, Issue:2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Dose-Response Relationship, Drug; Duodenal Ulcer; Gastroesophageal Reflux; Humans; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Stomach Ulcer; Sulfoxides

1999
The efficacy of proton-pump inhibitors in acute ulcer bleeding: a qualitative review.
    Journal of clinical gastroenterology, 2000, Volume: 30, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Duodenal Ulcer; Humans; Lansoprazole; Omeprazole; Pantoprazole; Peptic Ulcer Hemorrhage; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Recurrence; Stomach Ulcer; Sulfoxides; Treatment Outcome

2000
Is it time to adopt proton pump inhibitors in the prevention of non-steroidal anti-inflammatory drug gastropathy?
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2000, Volume: 32, Issue:3

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Inflammatory Agents, Non-Steroidal; Benzimidazoles; Enzyme Inhibitors; Humans; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Stomach Diseases; Sulfoxides

2000
Are the orally administered proton pump inhibitors equivalent? A comparison of lansoprazole, omeprazole, pantoprazole, and rabeprazole.
    Current gastroenterology reports, 2000, Volume: 2, Issue:6

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Drug Interactions; Duodenal Ulcer; Gastroesophageal Reflux; Humans; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Sulfoxides

2000
[H2 receptor antagonists and proton pump inhibitors: principles and rules of use].
    La Revue du praticien, 2001, Apr-15, Volume: 51, Issue:7

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Age Factors; Aged; Anti-Ulcer Agents; Benzimidazoles; Child; Child, Preschool; Duodenal Ulcer; Enzyme Inhibitors; Esophagitis, Peptic; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Infant; Infant, Newborn; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Ranitidine; Stomach Ulcer; Sulfoxides

2001
Proton pump inhibitors and their drug interactions: an evidence-based approach.
    European journal of gastroenterology & hepatology, 2001, Volume: 13, Issue:5

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Drug Interactions; Enzyme Inhibitors; Gastrointestinal Agents; Humans; Lansoprazole; Mixed Function Oxygenases; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Sulfoxides

2001
Shortcomings of the first-generation proton pump inhibitors.
    European journal of gastroenterology & hepatology, 2001, Volume: 13 Suppl 1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Biological Availability; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Gastric Acid; Gastroesophageal Reflux; Humans; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides

2001
Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton-pump inhibitors lansoprazole, rabeprazole, and pantoprazole compared with omeprazole, ranitidine, and placebo: evidence from randomized clinical trials.
    Clinical therapeutics, 2001, Volume: 23, Issue:7

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Gastroesophageal Reflux; Humans; Lansoprazole; Omeprazole; Pantoprazole; Rabeprazole; Randomized Controlled Trials as Topic; Ranitidine; Sulfoxides; Treatment Outcome

2001
[Comparative study of proton pump inhibitors].
    Orvosi hetilap, 2001, Sep-09, Volume: 142, Issue:36

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Cytochrome P-450 Enzyme Inhibitors; Drug Interactions; Duodenal Ulcer; Enzyme Inhibitors; Gastric Acid; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Proton-Translocating ATPases; Rabeprazole; Stomach Ulcer; Sulfoxides

2001
Review article: rabeprazole-based therapy in Helicobacter pylori eradication.
    Alimentary pharmacology & therapeutics, 2002, Volume: 16 Suppl 1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Clinical Trials as Topic; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Pantoprazole; Peptic Ulcer; Proton Pump Inhibitors; Rabeprazole; Sulfoxides

2002
Single vs. double dose of a proton pump inhibitor in triple therapy for Helicobacter pylori eradication: a meta-analysis.
    Alimentary pharmacology & therapeutics, 2002, Volume: 16, Issue:6

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Pantoprazole; Penicillins; Proton Pump Inhibitors; Rabeprazole; Sulfoxides; Treatment Outcome

2002
The pharmacology and clinical relevance of proton pump inhibitors.
    Current gastroenterology reports, 2002, Volume: 4, Issue:6

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Drug Administration Schedule; Drug Therapy, Combination; Enzyme Inhibitors; Gastric Acid; Gastroesophageal Reflux; Humans; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Sulfoxides; Treatment Outcome

2002
Recent use of proton pump inhibitor-based triple therapies for the eradication of H pylori: a broad data review.
    Helicobacter, 2003, Volume: 8, Issue:2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Clinical Trials as Topic; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides

2003
[All proton pump inhibitors are equally efficacious in standard dosages].
    Lakartidningen, 2003, Jun-19, Volume: 100, Issue:25

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Dose-Response Relationship, Drug; Enzyme Inhibitors; Esomeprazole; Gastric Acid; Gastroesophageal Reflux; Humans; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Sulfoxides

2003
[Use of proton pump inhibitors in the treatment of gastroesophageal reflux disease].
    Klinicheskaia meditsina, 2003, Volume: 81, Issue:9

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Enzyme Inhibitors; Gastroesophageal Reflux; Humans; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Sulfoxides; Treatment Outcome

2003
Effectiveness of proton pump inhibitors: beyond cost.
    Reviews in gastroenterological disorders, 2004, Volume: 4 Suppl 4

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Enzyme Inhibitors; Esophagitis; Gastroesophageal Reflux; Humans; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Sulfoxides; Treatment Outcome

2004
What is potent acid inhibition, and how can it be achieved?
    Drugs, 2005, Volume: 65 Suppl 1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Clinical Trials as Topic; Esomeprazole; Gastric Acid; Humans; Lansoprazole; Omeprazole; Pantoprazole; Peptic Ulcer; Proton Pump Inhibitors; Rabeprazole; Sulfoxides

2005
Gastroesophageal reflux disease and extraesophageal disease.
    Reviews in gastroenterological disorders, 2005, Volume: 5 Suppl 2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Asthma; Benzimidazoles; Esophageal pH Monitoring; Gastric Acidity Determination; Gastroesophageal Reflux; Heart Diseases; Humans; Lansoprazole; Lung Diseases; Omeprazole; Otorhinolaryngologic Diseases; Pantoprazole; Proton Pump Inhibitors; Sulfoxides; Treatment Outcome

2005
Intravenous proton pump inhibitors.
    Reviews in gastroenterological disorders, 2006,Winter, Volume: 6, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Biological Availability; Drug Interactions; Esomeprazole; Humans; Hydrogen-Ion Concentration; Injections, Intravenous; Lansoprazole; Pantoprazole; Proton Pump Inhibitors; Stomach; Sulfoxides

2006
Myopathy including polymyositis: a likely class adverse effect of proton pump inhibitors?
    European journal of clinical pharmacology, 2006, Volume: 62, Issue:6

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adverse Drug Reaction Reporting Systems; Enzyme Inhibitors; Esomeprazole; Humans; Lansoprazole; Muscular Diseases; Myositis; Omeprazole; Pantoprazole; Polymyositis; Proton Pump Inhibitors; Rabeprazole; Rhabdomyolysis

2006
Anaphylactic reaction to drugs commonly used for gastrointestinal system diseases: 3 case reports and review of the literature.
    Journal of investigational allergology & clinical immunology, 2006, Volume: 16, Issue:3

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anaphylaxis; Anti-Ulcer Agents; Benzimidazoles; Famotidine; Female; Gastroesophageal Reflux; Gastrointestinal Diseases; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pantoprazole; Ranitidine; Skin Tests

2006
Systematic review: proton pump inhibitors (PPIs) for the healing of reflux oesophagitis - a comparison of esomeprazole with other PPIs.
    Alimentary pharmacology & therapeutics, 2006, Sep-01, Volume: 24, Issue:5

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Clinical Trials as Topic; Enzyme Inhibitors; Esomeprazole; Esophagitis, Peptic; Humans; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Treatment Outcome

2006
[Dosaging of proton pumps inhibitors].
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2006, Sep-21, Volume: 126, Issue:18

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Antacids; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; Cytochrome P-450 CYP2C19; Enzyme Inhibitors; Gastroesophageal Reflux; Genotype; Humans; Lansoprazole; Mixed Function Oxygenases; Omeprazole; Pantoprazole; Pharmacogenetics; Polymorphism, Genetic; Proton Pump Inhibitors; Sulfoxides

2006
[Safety of proton pump inhibitors].
    Medicina clinica, 2006, Nov-25, Volume: 127, Issue:20

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Adult; Age Factors; Aged; Animals; Anti-Ulcer Agents; Cimetidine; Enzyme Inhibitors; Famotidine; Female; Fetus; Histamine H2 Antagonists; Humans; Lactation; Lansoprazole; Meta-Analysis as Topic; Nizatidine; Omeprazole; Pantoprazole; Pregnancy; Proton Pump Inhibitors; Proton-Translocating ATPases; Rabeprazole; Ranitidine; Safety; Time Factors

2006
[Clinical pharmacological aspects of the proton pump inhibitor therapy: importance of pharmacogenetic differences in the clinical practice].
    Orvosi hetilap, 2007, Mar-25, Volume: 148, Issue:12

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Drug Interactions; Enzyme Inhibitors; Esomeprazole; Humans; Lansoprazole; Liver; Omeprazole; Pantoprazole; Polymorphism, Genetic; Proton Pump Inhibitors; Rabeprazole

2007
Stereoselective disposition of proton pump inhibitors.
    Clinical drug investigation, 2008, Volume: 28, Issue:5

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Esomeprazole; Humans; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Stereoisomerism

2008
[Proton pump inhibitors, a family of drugs in continuous expansion].
    Minerva gastroenterologica e dietologica, 2000, Volume: 46, Issue:4

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Inflammatory Agents, Non-Steroidal; Barrett Esophagus; Duodenal Ulcer; Dyspepsia; Gastric Acid; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Rats; Stomach Ulcer

2000
[Prevention of GI bleeding due to antiplatelet agents: a labyrinth!].
    Presse medicale (Paris, France : 1983), 2009, Volume: 38, Issue:12

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aspirin; Clopidogrel; Drug Interactions; Drug Therapy, Combination; Gastrointestinal Hemorrhage; Humans; Lansoprazole; Omeprazole; Pantoprazole; Platelet Aggregation; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Risk Factors; Ticlopidine

2009
Impact of oesophagitis classification in evaluating healing of erosive oesophagitis after therapy with proton pump inhibitors: a pooled analysis.
    European journal of gastroenterology & hepatology, 2010, Volume: 22, Issue:5

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Databases, Factual; Endoscopy, Gastrointestinal; Esomeprazole; Esophagitis; Humans; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Randomized Controlled Trials as Topic; Registries; Wound Healing

2010
Efficacy of proton-pump inhibitors in children with gastroesophageal reflux disease: a systematic review.
    Pediatrics, 2011, Volume: 127, Issue:5

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Age Factors; Child; Child, Preschool; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gastroesophageal Reflux; Humans; Incidence; Infant; Lansoprazole; Male; Netherlands; Omeprazole; Pantoprazole; Prognosis; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Risk Assessment; Treatment Outcome

2011
The association between the use of proton pump inhibitors and the risk of hypomagnesemia: a systematic review and meta-analysis.
    PloS one, 2014, Volume: 9, Issue:11

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Dexlansoprazole; Esomeprazole; Humans; Lansoprazole; Magnesium; Odds Ratio; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Risk Factors; Treatment Outcome

2014
Comparative effectiveness and acceptability of the FDA-licensed proton pump inhibitors for erosive esophagitis: A PRISMA-compliant network meta-analysis.
    Medicine, 2017, Volume: 96, Issue:39

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Comparative Effectiveness Research; Dexlansoprazole; Esomeprazole; Esophagitis, Peptic; Female; Heartburn; Humans; Lansoprazole; Male; Middle Aged; Network Meta-Analysis; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Treatment Outcome; United States; United States Food and Drug Administration

2017
High-dose vs. Low-dose Proton Pump Inhibitors post-endoscopic hemostasis in patients with bleeding peptic ulcer. A meta-analysis and meta-regression analysis.
    The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2018, Volume: 29, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Dose-Response Relationship, Drug; Female; Hemostasis, Endoscopic; Humans; Lansoprazole; Male; Middle Aged; Pantoprazole; Peptic Ulcer Hemorrhage; Postoperative Hemorrhage; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Regression Analysis; Treatment Outcome

2018
Proton Pump Inhibitors and Bone Health: An Update Narrative Review.
    International journal of molecular sciences, 2022, 09-14, Volume: 23, Issue:18

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Antacids; Bone Density; Dexlansoprazole; Esomeprazole; Humans; Lansoprazole; Omeprazole; Osteoporotic Fractures; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; United States

2022

Trials

42 trial(s) available for pantoprazole and lansoprazole

ArticleYear
Twenty-four-hour monitoring of intragastric acidity: comparison between lansoprazole 30mg and pantoprazole 40mg.
    European journal of gastroenterology & hepatology, 1997, Volume: 9, Issue:2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Benzimidazoles; Cross-Over Studies; Female; Gastric Acid; Humans; Hydrogen-Ion Concentration; Lansoprazole; Male; Monitoring, Physiologic; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides

1997
Pharmacokinetics and effect on caffeine metabolism of the proton pump inhibitors, omeprazole, lansoprazole, and pantoprazole.
    British journal of clinical pharmacology, 1998, Volume: 45, Issue:4

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Area Under Curve; Benzimidazoles; Breath Tests; Caffeine; Humans; Lansoprazole; Male; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides

1998
A comparison of omeprazole, lansoprazole and pantoprazole in the maintenance treatment of severe reflux oesophagitis.
    Alimentary pharmacology & therapeutics, 1998, Volume: 12, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Deglutition Disorders; Double-Blind Method; Endoscopy; Esophageal Stenosis; Gastroesophageal Reflux; Heartburn; Humans; Lansoprazole; Middle Aged; Omeprazole; Pantoprazole; Prospective Studies; Proton Pump Inhibitors; Secondary Prevention; Sulfoxides; Treatment Outcome

1998
Three-day antibiotic therapy with azithromycin and tinidazole plus lansoprazole or pantoprazole to cure Helicobacter pylori infection: a pilot study.
    European journal of gastroenterology & hepatology, 1999, Volume: 11, Issue:3

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Azithromycin; Benzimidazoles; Drug Therapy, Combination; Duodenal Ulcer; Enzyme Inhibitors; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pantoprazole; Pilot Projects; Prospective Studies; Proton Pump Inhibitors; Stomach Ulcer; Sulfoxides; Tinidazole

1999
Lack of drug interaction between omeprazole, lansoprazole, pantoprazole and theophylline.
    British journal of clinical pharmacology, 1999, Volume: 48, Issue:3

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Area Under Curve; Benzimidazoles; Bronchodilator Agents; Cross-Over Studies; Cytochrome P-450 CYP1A2; Double-Blind Method; Drug Interactions; Female; Humans; Lansoprazole; Male; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides; Theophylline

1999
Lack of a pharmacokinetic interaction between lansoprazole or pantoprazole and theophylline.
    Alimentary pharmacology & therapeutics, 2000, Volume: 14, Issue:3

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Anti-Ulcer Agents; Area Under Curve; Benzimidazoles; Biological Availability; Bronchodilator Agents; Delayed-Action Preparations; Drug Interactions; Humans; Lansoprazole; Linear Models; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Single-Blind Method; Sulfoxides; Theophylline

2000
Influence of Helicobacter pylori eradication therapy on 13C aminopyrine breath test: comparison among omeprazole-, lansoprazole-, or pantoprazole-containing regimens.
    The American journal of gastroenterology, 2000, Volume: 95, Issue:10

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aminopyrine; Anti-Ulcer Agents; Benzimidazoles; Breath Tests; Carbon Radioisotopes; Clarithromycin; Cytochrome P-450 Enzyme Inhibitors; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Peptic Ulcer; Proton Pump Inhibitors; Sulfoxides

2000
Pantoprazole versus lansoprazole in French patients with reflux esophagitis.
    Gastroenterologie clinique et biologique, 2001, Volume: 25, Issue:3

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Esophagitis, Peptic; Esophagoscopy; Female; France; Heartburn; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pain; Pantoprazole; Prospective Studies; Sulfoxides

2001
Effects on 24-hour intragastric pH: a comparison of lansoprazole administered nasogastrically in apple juice and pantoprazole administered intravenously.
    The American journal of gastroenterology, 2001, Volume: 96, Issue:7

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Anti-Ulcer Agents; Benzimidazoles; Cross-Over Studies; Enzyme Inhibitors; Female; Humans; Hydrogen-Ion Concentration; Injections, Intravenous; Intubation, Gastrointestinal; Kinetics; Lansoprazole; Male; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Random Allocation; Rosales; Stomach; Sulfoxides

2001
A comparison of simplified lansoprazole suspension administered nasogastrically and pantoprazole administered intravenously: effects on 24-h intragastric pH.
    Alimentary pharmacology & therapeutics, 2001, Volume: 15, Issue:11

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Benzimidazoles; Cross-Over Studies; Enzyme Inhibitors; Female; Gastric Acid; Gastric Acidity Determination; Humans; Hydrogen-Ion Concentration; Infusions, Intravenous; Intubation, Gastrointestinal; Lansoprazole; Middle Aged; Omeprazole; Pantoprazole; Sulfoxides; Suspensions

2001
Acid suppression in healthy subjects following lansoprazole or pantoprazole.
    Alimentary pharmacology & therapeutics, 2002, Volume: 16, Issue:3

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Anti-Ulcer Agents; Benzimidazoles; Cross-Over Studies; Gastric Acid; Gastric Acidity Determination; Humans; Hydrogen-Ion Concentration; Lansoprazole; Male; Monitoring, Physiologic; Omeprazole; Pantoprazole; Single-Blind Method; Sulfoxides

2002
Different effects of short-term omeprazole, lansoprazole or pantoprazole on the accuracy of the (13)C-urea breath test.
    Alimentary pharmacology & therapeutics, 2002, Volume: 16, Issue:3

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Benzimidazoles; Breath Tests; Carbon Isotopes; Drug Interactions; False Negative Reactions; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pantoprazole; Sensitivity and Specificity; Sulfoxides; Time Factors; Urea

2002
Effect of pantoprazole versus other proton pump inhibitors on 24-hour intragastric pH and basal acid output in Zollinger-Ellison syndrome.
    Gastroenterologie clinique et biologique, 2002, Volume: 26, Issue:4

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Female; Gastric Acid; Gastric Acidity Determination; Gastrins; Humans; Lansoprazole; Male; Omeprazole; Pantoprazole; Prospective Studies; Proton Pump Inhibitors; Sulfoxides; Time Factors; Zollinger-Ellison Syndrome

2002
A double-blind, randomized comparison of omeprazole Multiple Unit Pellet System (MUPS) 20 mg, lansoprazole 30 mg and pantoprazole 40 mg in symptomatic reflux oesophagitis followed by 3 months of omeprazole MUPS maintenance treatment: a Dutch multicentre t
    European journal of gastroenterology & hepatology, 2002, Volume: 14, Issue:6

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Enzyme Inhibitors; Esophagitis, Peptic; Female; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pantoprazole; Patient Satisfaction; Proton Pump Inhibitors; Sulfoxides

2002
Effective intra-oesophageal acid suppression in patients with gastro-oesophageal reflux disease: lansoprazole vs. pantoprazole.
    Alimentary pharmacology & therapeutics, 2003, Volume: 17, Issue:2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Dose-Response Relationship, Drug; Esophagitis, Peptic; Gastric Acid; Gastroesophageal Reflux; Humans; Hydrogen-Ion Concentration; Lansoprazole; Manometry; Middle Aged; Omeprazole; Pantoprazole; Sulfoxides

2003
Acid inhibition on the first day of dosing: comparison of four proton pump inhibitors.
    Alimentary pharmacology & therapeutics, 2003, Jun-15, Volume: 17, Issue:12

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Antacids; Benzimidazoles; Cross-Over Studies; Double-Blind Method; Female; Gastric Acid; Humans; Hydrogen-Ion Concentration; Lansoprazole; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Sulfoxides; Time Factors

2003
Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: a five-way crossover study.
    The American journal of gastroenterology, 2003, Volume: 98, Issue:12

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Anti-Ulcer Agents; Benzimidazoles; Chi-Square Distribution; Cross-Over Studies; Esomeprazole; Female; Gastric Acid; Gastroesophageal Reflux; Humans; Hydrogen-Ion Concentration; Lansoprazole; Least-Squares Analysis; Male; Middle Aged; Omeprazole; Pantoprazole; Rabeprazole; Sulfoxides; Treatment Outcome

2003
Masking of 13C urea breath test by proton pump inhibitors is dependent on type of medication: comparison between omeprazole, pantoprazole, lansoprazole and esomeprazole.
    Alimentary pharmacology & therapeutics, 2004, Jul-01, Volume: 20, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Infective Agents; Anti-Ulcer Agents; Benzimidazoles; Breath Tests; Esomeprazole; False Negative Reactions; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pantoprazole; Prospective Studies; Proton Pump Inhibitors; Sulfoxides; Urea

2004
In treatment of active duodenal ulcer and Helicobacter pylori eradication.
    Hepato-gastroenterology, 2003, Volume: 50 Suppl 2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides; Treatment Outcome

2003
Esomeprazole 40 mg provides more effective intragastric acid control than lansoprazole 30 mg, omeprazole 20 mg, pantoprazole 40 mg and rabeprazole 20 mg in patients with gastro-oesophageal reflux symptoms.
    European journal of clinical pharmacology, 2004, Volume: 60, Issue:8

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Anti-Ulcer Agents; Benzimidazoles; Cross-Over Studies; Esomeprazole; Female; Gastric Acid; Gastroesophageal Reflux; Humans; Hydrogen-Ion Concentration; Lansoprazole; Male; Middle Aged; Omeprazole; Pantoprazole; Rabeprazole; Sulfoxides; Treatment Outcome

2004
Helicobacter pylori infection and the prevention of peptic ulcer with proton pump inhibitors in elderly subjects taking low-dose aspirin.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2004, Volume: 36, Issue:10

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Benzimidazoles; Dose-Response Relationship, Drug; Endoscopes, Gastrointestinal; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Pantoprazole; Peptic Ulcer; Prospective Studies; Proton Pump Inhibitors; Sulfoxides

2004
The safety of proton pump inhibitors in pregnancy: a multicentre prospective controlled study.
    Alimentary pharmacology & therapeutics, 2005, Feb-01, Volume: 21, Issue:3

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abnormalities, Drug-Induced; Adult; Anti-Ulcer Agents; Benzimidazoles; Female; Gastroesophageal Reflux; Humans; Lansoprazole; Omeprazole; Pantoprazole; Peptic Ulcer; Pregnancy; Pregnancy Complications; Pregnancy Trimester, First; Prospective Studies; Proton Pump Inhibitors; Sulfoxides

2005
Influence of various proton pump inhibitors on intestinal metaplasia in noneradicated Helicobacter pylori patients.
    World journal of gastroenterology, 2005, Apr-21, Volume: 11, Issue:15

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Benzimidazoles; Chronic Disease; Enzyme Inhibitors; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Intestines; Lansoprazole; Male; Metaplasia; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides

2005
Recent success of pantoprazole -or lansoprazole- based clarithromycin plus amoxicillin treatment in the eradication of Helicobacter pylori.
    The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2004, Volume: 15, Issue:4

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Single-Blind Method; Sulfoxides; Treatment Outcome

2004
Lansoprazole regimens that sustain intragastric pH > 6.0: an evaluation of intermittent oral and continuous intravenous infusion dosages.
    Alimentary pharmacology & therapeutics, 2006, Apr-01, Volume: 23, Issue:7

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adolescent; Adult; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; Cross-Over Studies; Cytochrome P-450 CYP2C19; Dose-Response Relationship, Drug; Female; Gastric Acidity Determination; Genotype; Humans; Hydrogen-Ion Concentration; Infusions, Intravenous; Lansoprazole; Male; Metabolic Clearance Rate; Middle Aged; Mixed Function Oxygenases; Omeprazole; Pantoprazole; Sulfoxides; Tablets

2006
Intragastric acid control in non-steroidal anti-inflammatory drug users: comparison of esomeprazole, lansoprazole and pantoprazole.
    Alimentary pharmacology & therapeutics, 2006, Apr-15, Volume: 23, Issue:8

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Benzimidazoles; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Gastric Acid; Gastric Acidity Determination; Humans; Hydrogen-Ion Concentration; Lansoprazole; Least-Squares Analysis; Male; Middle Aged; Pantoprazole; Proton Pump Inhibitors; Sulfoxides

2006
Comparison of four proton pump inhibitors for the short-term treatment of esophagitis in elderly patients.
    World journal of gastroenterology, 2007, Sep-07, Volume: 13, Issue:33

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Anti-Ulcer Agents; Endoscopy, Gastrointestinal; Esophagitis; Female; Humans; Lansoprazole; Male; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Treatment Outcome

2007
Effect of CYP2C19*2 and *17 mutations on pharmacodynamics and kinetics of proton pump inhibitors in Caucasians.
    British journal of clinical pharmacology, 2008, Volume: 65, Issue:5

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Cross-Over Studies; Cytochrome P-450 CYP2C19; Female; Gastric Acidity Determination; Humans; Lansoprazole; Male; Mixed Function Oxygenases; Mutation; Omeprazole; Pantoprazole; Proton Pump Inhibitors

2008
Ninety-six-hour wireless oesophageal pH monitoring following proton pump inhibitor administration in NERD patients.
    Alimentary pharmacology & therapeutics, 2008, Volume: 28, Issue:2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Esophageal pH Monitoring; Female; Gastroesophageal Reflux; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Treatment Outcome

2008
Control of 24-hour intragastric acidity with morning dosing of immediate-release and delayed-release proton pump inhibitors in patients with GERD.
    Journal of clinical gastroenterology, 2009, Volume: 43, Issue:4

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adolescent; Adult; Cross-Over Studies; Delayed-Action Preparations; Drug Administration Schedule; Female; Gastric Acid; Gastric Acidity Determination; Gastroesophageal Reflux; Humans; Hydrogen-Ion Concentration; Lansoprazole; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Treatment Outcome; Young Adult

2009
Comparative study of omeprazole, lansoprazole, pantoprazole and esomeprazole for symptom relief in patients with reflux esophagitis.
    World journal of gastroenterology, 2009, Feb-28, Volume: 15, Issue:8

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Esomeprazole; Female; Gastroesophageal Reflux; Heartburn; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pantoprazole; Patient Selection

2009
Clinical trial: gastric acid suppression in Hispanic adults with symptomatic gastro-oesophageal reflux disease - comparator study of esomeprazole, lansoprazole and pantoprazole.
    Alimentary pharmacology & therapeutics, 2010, Volume: 32, Issue:2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Anti-Ulcer Agents; Cross-Over Studies; Drug Therapy, Combination; Esomeprazole; Female; Gastric Acid; Gastroesophageal Reflux; Hispanic or Latino; Humans; Lansoprazole; Male; Middle Aged; Pantoprazole; Patient Compliance; Treatment Outcome; United States; Young Adult

2010
Improved HPLC method for determination of four PPIs, omeprazole, pantoprazole, lansoprazole and rabeprazole in human plasma.
    Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques, 2010, Volume: 13, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Chromatography, High Pressure Liquid; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Reproducibility of Results; Young Adult

2010
Inhibitory effects of intravenous lansoprazole 30 mg and pantoprazole 40 mg twice daily on intragastric acidity in healthy Chinese volunteers: a randomized, open-labeled, two-way crossover study.
    Medical science monitor : international medical journal of experimental and clinical research, 2012, Volume: 18, Issue:2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Base Sequence; China; Cross-Over Studies; DNA Primers; Female; Gastric Acid; Humans; Hydrogen-Ion Concentration; Infusions, Intravenous; Lansoprazole; Male; Pantoprazole; Polymerase Chain Reaction; Reference Values

2012
Enantioselective disposition of omeprazole, pantoprazole, and lansoprazole in a same Brazilian subjects group.
    Chirality, 2012, Volume: 24, Issue:4

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Brazil; Humans; Lansoprazole; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Stereoisomerism; Substrate Specificity; Young Adult

2012
Probiotics for standard triple Helicobacter pylori eradication: a randomized, double-blind, placebo-controlled trial.
    Medicine, 2015, Volume: 94, Issue:17

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bifidobacterium; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lacticaseibacillus rhamnosus; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Placebos; Probiotics; Prospective Studies; Proton Pump Inhibitors; Surveys and Questionnaires; Treatment Outcome

2015
In vitro and in vivo evaluation of drug-drug interaction between dabigatran and proton pump inhibitors.
    Fundamental & clinical pharmacology, 2015, Volume: 29, Issue:6

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; ATP Binding Cassette Transporter, Subfamily B, Member 1; Caco-2 Cells; Cell Line, Tumor; Cyclosporine; Dabigatran; Drug Interactions; Humans; Lansoprazole; Male; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Thrombin; Young Adult

2015
Cognitive impact after short-term exposure to different proton pump inhibitors: assessment using CANTAB software.
    Alzheimer's research & therapy, 2015, Dec-27, Volume: 7

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Cognition; Esomeprazole; Female; Humans; Lansoprazole; Male; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Software; Young Adult

2015
One year treatment of Barrett's oesophagus with proton pump inhibitors (a multi-center study).
    Acta clinica Belgica, 2015, Volume: 70, Issue:6

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Barrett Esophagus; Epithelial Cells; Esophagoscopy; Esophagus; Humans; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors

2015
[Comparison on Oral versus Intravenous Proton Pump Inhibitors for Prevention of Bleeding after Endoscopic Submucosal Dissection of Gastric Lesions].
    The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2016, Volume: 67, Issue:2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Aged; Anticoagulants; Endoscopic Mucosal Resection; Female; Gastroscopy; Humans; Injections, Intravenous; Lansoprazole; Male; Middle Aged; Odds Ratio; Pantoprazole; Postoperative Hemorrhage; Prospective Studies; Proton Pump Inhibitors; Risk Factors; Stomach Neoplasms

2016
Comparison of the effects of esomeprazole 40 mg, rabeprazole 20 mg, lansoprazole 30 mg, and pantoprazole 40 mg on intragastrıc pH in extensive metabolizer patients with gastroesophageal reflux disease.
    The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2016, Volume: 27, Issue:5

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Cross-Over Studies; Cytochrome P-450 CYP2C19; Double-Blind Method; Esomeprazole; Female; Gastric Acid; Gastroesophageal Reflux; Genotype; Humans; Hydrogen-Ion Concentration; Lansoprazole; Male; Middle Aged; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Treatment Outcome

2016
Lansoprazole use and tuberculosis incidence in the United Kingdom Clinical Practice Research Datalink: A population based cohort.
    PLoS medicine, 2017, Volume: 14, Issue:11

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Cohort Studies; Female; Humans; Incidence; Lansoprazole; Male; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Tuberculosis; United Kingdom

2017

Other Studies

115 other study(ies) available for pantoprazole and lansoprazole

ArticleYear
(H+,K+)-ATPase inhibiting 2-[(2-pyridylmethyl)sulfinyl]benzimidazoles. 4. A novel series of dimethoxypyridyl-substituted inhibitors with enhanced selectivity. The selection of pantoprazole as a clinical candidate.
    Journal of medicinal chemistry, 1992, Mar-20, Volume: 35, Issue:6

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Adenosine Triphosphate; Animals; Benzimidazoles; Dogs; Gastric Mucosa; H(+)-K(+)-Exchanging ATPase; Omeprazole; Pantoprazole; Pyridines; Rabbits; Structure-Activity Relationship; Sulfoxides

1992
Nicotinamide derivatives as a new class of gastric H+/K(+)-ATPase inhibitors. 1. Synthesis and structure-activity relationships of N-substituted 2-(benzhydryl- and benzylsulfinyl)nicotinamides.
    Journal of medicinal chemistry, 1997, Jan-31, Volume: 40, Issue:3

    Topics: Aminopyrine; Animals; Bucladesine; Enzyme Inhibitors; Gastric Acid; Hydrogen-Ion Concentration; Kinetics; Magnetic Resonance Spectroscopy; Male; Mass Spectrometry; Molecular Structure; Niacinamide; Parietal Cells, Gastric; Proton Pump Inhibitors; Pyridines; Rabbits; Rats; Rats, Wistar; Structure-Activity Relationship

1997
Interaction of omeprazole, lansoprazole and pantoprazole with P-glycoprotein.
    Naunyn-Schmiedeberg's archives of pharmacology, 2001, Volume: 364, Issue:6

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzimidazoles; Biological Transport; Caco-2 Cells; Digoxin; Drug Interactions; Enzyme Inhibitors; Epithelial Cells; Humans; Lansoprazole; LLC-PK1 Cells; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Proton Pumps; Sulfoxides; Swine

2001
Hologram QSAR model for the prediction of human oral bioavailability.
    Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24

    Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations

2010
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
    Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6

    Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics

2010
Antiprotozoal activity of proton-pump inhibitors.
    Bioorganic & medicinal chemistry letters, 2011, Dec-15, Volume: 21, Issue:24

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Antiprotozoal Agents; Drug Design; Entamoeba histolytica; Giardia lamblia; Humans; Lansoprazole; Omeprazole; Pantoprazole; Parasitic Diseases; Proton Pump Inhibitors; Rabeprazole; Trichomonas vaginalis

2011
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
    Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10

    Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection

2012
Identification of selective inhibitors of indoleamine 2,3-dioxygenase 2.
    Bioorganic & medicinal chemistry letters, 2012, Dec-15, Volume: 22, Issue:24

    Topics: Animals; Dose-Response Relationship, Drug; Enzyme Inhibitors; HEK293 Cells; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Mice; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Substrate Specificity

2012
Which metabolites circulate?
    Drug metabolism and disposition: the biological fate of chemicals, 2013, Volume: 41, Issue:5

    Topics: Humans; Metabolic Clearance Rate; Pharmaceutical Preparations

2013
Repositioning proton pump inhibitors as anticancer drugs by targeting the thioesterase domain of human fatty acid synthase.
    Journal of medicinal chemistry, 2015, Jan-22, Volume: 58, Issue:2

    Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Drug Repositioning; Fatty Acid Synthases; Humans; Hydrogen-Ion Concentration; Lansoprazole; Palmitic Acid; Palmitoyl-CoA Hydrolase; Protein Structure, Tertiary; Proton Pump Inhibitors

2015
Identification of ebselen as a potent inhibitor of insulin degrading enzyme by a drug repurposing screening.
    European journal of medicinal chemistry, 2019, Oct-01, Volume: 179

    Topics: Azoles; Biocatalysis; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Repositioning; Enzyme Inhibitors; High-Throughput Screening Assays; Humans; Insulysin; Isoindoles; Molecular Structure; Organoselenium Compounds; Structure-Activity Relationship

2019
The H+, K(+)-ATPase inhibitor pantoprazole (BY1023/SK&F96022) interacts less with cytochrome P450 than omeprazole and lansoprazole.
    Biochemical pharmacology, 1991, Jul-05, Volume: 42, Issue:2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; 7-Alkoxycoumarin O-Dealkylase; Adenosine Triphosphatases; Animals; Benzimidazoles; Biotransformation; Cytochrome P-450 Enzyme Inhibitors; Drug Interactions; Ethylmorphine-N-Demethylase; Female; H(+)-K(+)-Exchanging ATPase; Kinetics; Lansoprazole; Liver; Omeprazole; Pantoprazole; Pyrazoles; Rats; Rats, Inbred Strains; Sulfoxides

1991
Metabolic interactions of the proton-pump inhibitors lansoprazole, omeprazole and pantoprazole with other drugs.
    European journal of gastroenterology & hepatology, 1996, Volume: 8 Suppl 1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Humans; Lansoprazole; Mixed Function Oxygenases; Omeprazole; Pantoprazole; Peptic Ulcer; Polymorphism, Genetic; Proton Pump Inhibitors; Structure-Activity Relationship; Sulfoxides

1996
[Do other proton pump blockers have advantages over Antra (omeprazole)?].
    Der Internist, 1996, Volume: 37, Issue:9

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Humans; Lansoprazole; Omeprazole; Pantoprazole; Peptic Ulcer; Structure-Activity Relationship; Sulfoxides

1996
[2 new proton pump inhibitors. Possibilities of pantoprazole and lansoprazole].
    Der Internist, 1996, Volume: 37, Issue:9

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Humans; Lansoprazole; Omeprazole; Pantoprazole; Peptic Ulcer; Structure-Activity Relationship; Sulfoxides; Treatment Outcome

1996
Effects of benzimidazole derivatives on cytochrome P450 1A1 expression in a human hepatoma cell line.
    Xenobiotica; the fate of foreign compounds in biological systems, 1997, Volume: 27, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; beta-Naphthoflavone; Cell Line; Cytochrome P-450 CYP1A1; Enzyme Activation; Humans; Lansoprazole; Omeprazole; Pantoprazole; Rabeprazole; RNA, Messenger; Sulfoxides

1997
Chiral resolution of pantoprazole sodium and related sulfoxides by complex formation with bovine serum albumin in capillary electrophoresis.
    Journal of chromatography. A, 1997, Jan-24, Volume: 759, Issue:1-2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Electrophoresis, Capillary; Hydrogen-Ion Concentration; Lansoprazole; Omeprazole; Pantoprazole; Serum Albumin, Bovine; Spectrophotometry, Ultraviolet; Stereoisomerism; Sulfoxides

1997
Effects of pantoprazole on xenobiotic metabolizing enzymes in rat liver microsomes: a comparison with other proton pump inhibitors.
    Drug metabolism and disposition: the biological fate of chemicals, 1997, Volume: 25, Issue:5

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Benzimidazoles; Blotting, Western; Cytochrome P-450 Enzyme System; Cytochromes b5; Enzyme Induction; Enzyme Inhibitors; Female; Lansoprazole; Microsomes, Liver; NADPH-Ferrihemoprotein Reductase; Omeprazole; Organ Size; Pantoprazole; Proton Pump Inhibitors; Rats; Rats, Sprague-Dawley; Sulfoxides

1997
Proton-pump inhibitors: three of a kind?
    Lancet (London, England), 1997, Jun-07, Volume: 349, Issue:9066

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Enzyme Inhibitors; Humans; Lansoprazole; Omeprazole; Pantoprazole; Peptic Ulcer; Proton Pump Inhibitors; Sulfoxides

1997
Sites of reaction of the gastric H,K-ATPase with extracytoplasmic thiol reagents.
    The Journal of biological chemistry, 1997, Sep-05, Volume: 272, Issue:36

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amino Acid Sequence; Animals; Anti-Ulcer Agents; Benzimidazoles; Enzyme Inhibitors; Gastric Acid; H(+)-K(+)-Exchanging ATPase; Indicators and Reagents; Lansoprazole; Molecular Sequence Data; Omeprazole; Oxidoreductases; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Sequence Homology, Amino Acid; Sphingosine; Stomach; Sulfhydryl Compounds; Sulfoxides; Swine

1997
An evaluation of the CYP1A induction potential of pantoprazole in primary rat hepatocytes: a comparison with other proton pump inhibitors.
    Chemico-biological interactions, 1997, Nov-06, Volume: 107, Issue:1-2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Benzimidazoles; Blotting, Western; Cells, Cultured; Cytochrome P-450 CYP1A1; Enzyme Induction; Enzyme Inhibitors; Female; Lansoprazole; Liver; Microsomes, Liver; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rats; Rats, Sprague-Dawley; Sulfoxides

1997
Selective inhibition of the gastric H+,K(+)-ATPase by omeprazole and related compounds.
    Annals of the New York Academy of Sciences, 1997, Nov-03, Volume: 834

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Benzimidazoles; Binding Sites; Enzyme Inhibitors; Gastric Mucosa; H(+)-K(+)-Exchanging ATPase; Humans; Kinetics; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Structure-Activity Relationship; Sulfoxides; Valinomycin

1997
Effects of proton pump inhibitors on thyroid hormone metabolism in rats: a comparison of UDP-glucuronyltransferase induction.
    Biochemical pharmacology, 1997, Dec-01, Volume: 54, Issue:11

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Benzimidazoles; Bile; Enzyme Inhibitors; Female; Glucuronosyltransferase; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rats; Rats, Sprague-Dawley; Sulfoxides; Thyroid Hormones

1997
Growth inhibitory and bactericidal activities of lansoprazole compared with those of omeprazole and pantoprazole against Helicobacter pylori.
    Helicobacter, 1998, Volume: 3, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Growth Inhibitors; Helicobacter pylori; Humans; Lansoprazole; Microscopy, Electron, Scanning; Omeprazole; Pantoprazole; Sulfoxides; Urease

1998
An evaluation of the cytochrome P450 induction potential of pantoprazole in primary human hepatocytes.
    Chemico-biological interactions, 1998, Jul-03, Volume: 114, Issue:1-2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Benzimidazoles; Blotting, Western; Cells, Cultured; Cytochrome P-450 CYP1A1; Cytochrome P-450 Enzyme System; Enzyme Induction; Female; Humans; Lansoprazole; Liver; Male; Methylcholanthrene; Middle Aged; Omeprazole; Pantoprazole; Rifampin; Steroid Hydroxylases; Structure-Activity Relationship; Sulfoxides

1998
[Drug interactions. Proton pump inhibitors. 1].
    Der Internist, 1998, Volume: 39, Issue:8

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Drug Interactions; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides

1998
[Drug interactions. Proton pump inhibitors II].
    Der Internist, 1998, Volume: 39, Issue:9

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Cytochrome P-450 Enzyme System; Drug Interactions; Humans; Lansoprazole; Liver; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides

1998
Effects of pantoprazole, a novel H+/K+-ATPase inhibitor, on duodenal ulcerogenic and healing responses in rats: a comparative study with omeprazole and lansoprazole.
    Journal of gastroenterology and hepatology, 1999, Volume: 14, Issue:3

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acetic Acid; Animals; Anti-Ulcer Agents; Benzimidazoles; Bicarbonates; Dose-Response Relationship, Drug; Duodenal Ulcer; Enzyme Inhibitors; Epirizole; Gastric Acid; Lansoprazole; Male; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rats; Rats, Sprague-Dawley; Sulfoxides; Wound Healing

1999
Effect of various salts on the stability of lansoprazole, omeprazole, and pantoprazole as determined by high-performance liquid chromatography.
    Drug development and industrial pharmacy, 1999, Volume: 25, Issue:9

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Chromatography, High Pressure Liquid; Drug Stability; Enzyme Inhibitors; Hydrogen-Ion Concentration; Lansoprazole; Omeprazole; Pantoprazole; Reproducibility of Results; Salts; Sulfoxides; Time Factors

1999
Lichenoid drug eruption with proton pump inhibitors.
    BMJ (Clinical research ed.), 2000, Jan-29, Volume: 320, Issue:7230

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Benzimidazoles; Drug Eruptions; Enzyme Inhibitors; Humans; Lansoprazole; Lichenoid Eruptions; Male; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides

2000
Spectrophotometric methods for the determination of lansoprazole and pantoprazole sodium sesquihydrate.
    Journal of pharmaceutical and biomedical analysis, 2000, Volume: 22, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Calibration; Capsules; Hydrogen-Ion Concentration; Indicators and Reagents; Lansoprazole; Omeprazole; Pantoprazole; Pharmaceutical Solutions; Spectrophotometry, Ultraviolet; Sulfoxides; Tablets

2000
Treatment of Helicobacter pylori infection: is less more?
    Journal of clinical gastroenterology, 2000, Volume: 31, Issue:2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Clinical Trials as Topic; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Pantoprazole; Penicillins; Proton Pump Inhibitors; Sulfoxides; Time Factors

2000
The rates of common adverse events reported during treatment with proton pump inhibitors used in general practice in England: cohort studies.
    British journal of clinical pharmacology, 2000, Volume: 50, Issue:4

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Adult; Adverse Drug Reaction Reporting Systems; Age Distribution; Aged; Aged, 80 and over; Anti-Ulcer Agents; Benzimidazoles; Cohort Studies; Diarrhea; Drug Prescriptions; England; Family Practice; Female; Headache; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides

2000
Haloperidol-stomach lesions attenuation by pentadecapeptide BPC 157, omeprazole, bromocriptine, but not atropine, lansoprazole, pantoprazole, ranitidine, cimetidine and misoprostol in mice.
    Life sciences, 2001, Mar-09, Volume: 68, Issue:16

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Atropine; Benzimidazoles; Bromocriptine; Cimetidine; Disease Models, Animal; Domperidone; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Haloperidol; Indomethacin; Lansoprazole; Male; Mice; Mice, Inbred Strains; Misoprostol; Omeprazole; Pantoprazole; Peptide Fragments; Proteins; Ranitidine; Stomach Diseases; Sulfoxides

2001
Reversible pheripheral edema in female patients taking proton pump inhibitors for peptic acid diseases.
    Digestive diseases and sciences, 2001, Volume: 46, Issue:5

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Benzimidazoles; Edema; Female; Humans; Lansoprazole; Middle Aged; Omeprazole; Pantoprazole; Peptic Ulcer; Proton Pump Inhibitors; Sulfoxides

2001
Proton pump inhibitors: a study of GPs' prescribing.
    Family practice, 2001, Volume: 18, Issue:3

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Drug Costs; Drug Prescriptions; Drug Utilization; England; Family Practice; Female; Health Services Research; Hospitals, Teaching; Humans; Lansoprazole; Male; Omeprazole; Pantoprazole; Practice Patterns, Physicians'; Proton Pump Inhibitors; Sulfoxides

2001
Relative efficacies of gastric proton-pump inhibitors on a milligram basis: desired and undesired SH reactions. Impact of chirality.
    Scandinavian journal of gastroenterology. Supplement, 2001, Issue:234

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Enzyme Inhibitors; Esomeprazole; Half-Life; Humans; Hydrogen-Ion Concentration; Lansoprazole; Omeprazole; Pantoprazole; Parietal Cells, Gastric; Prodrugs; Proton Pump Inhibitors; Rabeprazole; Sulfoxides

2001
Conformational analysis: a new approach by means of chemometrics.
    Journal of computational chemistry, 2002, Jan-30, Volume: 23, Issue:2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Lansoprazole; Models, Molecular; Molecular Conformation; Omeprazole; Pantoprazole; Pharmaceutical Preparations; Sulfoxides; Thermodynamics

2002
Proton pump inhibitors: an update.
    American family physician, 2002, Jul-15, Volume: 66, Issue:2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Drug Interactions; Esomeprazole; Gastroesophageal Reflux; Humans; Lansoprazole; Omeprazole; Pantoprazole; Peptic Ulcer; Proton Pump Inhibitors; Rabeprazole; Sulfoxides

2002
[Submicroscopic aspects of the mechanism of inhibitors of H+/K+-ATPase in gastric parietal cells].
    Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology, 2002, Issue:3

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Enzyme Inhibitors; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Lansoprazole; Omeprazole; Pantoprazole; Parietal Cells, Gastric; Proton Pump Inhibitors; Sulfoxides

2002
Spectrophotometric determination of omeprazole, lansoprazole and pantoprazole in pharmaceutical formulations.
    Journal of pharmaceutical and biomedical analysis, 2002, Nov-07, Volume: 30, Issue:4

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Chemistry, Pharmaceutical; Lansoprazole; Omeprazole; Pantoprazole; Spectrophotometry, Ultraviolet; Sulfoxides

2002
[In small steps to far ahead. Diminished risk of interactions as definite advantage].
    MMW Fortschritte der Medizin, 2002, Oct-10, Volume: 144, Issue:41

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Drug Interactions; Humans; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides

2002
Differential drug-induced mRNA expression of human CYP3A4 compared to CYP3A5, CYP3A7 and CYP3A43.
    European journal of pharmacology, 2003, Apr-11, Volume: 466, Issue:1-2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; Cell Line, Tumor; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Gene Expression Regulation; Humans; Hypericum; Lansoprazole; Omeprazole; Pantoprazole; Plant Preparations; Rabeprazole; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sulfoxides

2003
A summary of Food and Drug Administration-reported adverse events and drug interactions occurring during therapy with omeprazole, lansoprazole and pantoprazole.
    Alimentary pharmacology & therapeutics, 2003, Volume: 17, Issue:8

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adverse Drug Reaction Reporting Systems; Anti-Ulcer Agents; Anticoagulants; Benzimidazoles; Drug Interactions; Gastrointestinal Diseases; Humans; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides; United States; United States Food and Drug Administration

2003
["Mirror, mirror on the wall which is the best proton pump inhibitor of all?"].
    Zeitschrift fur Gastroenterologie, 2003, Volume: 41, Issue:11

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Antifibrinolytic Agents; Benzimidazoles; Drug Interactions; Humans; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides; Vitamin K

2003
The acidity index: a simple approach to the measurement of gastric acidity.
    Alimentary pharmacology & therapeutics, 2004, Feb-15, Volume: 19, Issue:4

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Benzimidazoles; Female; Gastric Acid; Gastric Acidity Determination; Humans; Hydrogen-Ion Concentration; Lansoprazole; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides

2004
Pantoprazole treatment does not invoke anti-inflammatory properties in vivo.
    International immunopharmacology, 2004, Volume: 4, Issue:8

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Inflammatory Agents; Anti-Ulcer Agents; Benzimidazoles; Carrageenan; Helicobacter pylori; Inflammation; Lansoprazole; Male; Neutrophils; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rats; Rats, Wistar; Sulfoxides

2004
Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities.
    Drug metabolism and disposition: the biological fate of chemicals, 2004, Volume: 32, Issue:8

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Esomeprazole; Humans; Lansoprazole; Liver; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Proton Pumps; Rabeprazole; Sulfoxides

2004
Determination of pantoprazole in human plasma by LC-MS-MS using lansoprazole as internal standard.
    Arzneimittel-Forschung, 2004, Volume: 54, Issue:6

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Calibration; Chemistry, Pharmaceutical; Chromatography, Liquid; Humans; Indicators and Reagents; Lansoprazole; Mass Spectrometry; Omeprazole; Pantoprazole; Quality Control; Reference Standards; Reproducibility of Results; Sulfoxides; Therapeutic Equivalency

2004
Chiral separation of omeprazole and several related benzimidazoles using supercritical fluid chromatography.
    Journal of separation science, 2004, Volume: 27, Issue:12

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Alcohols; Amylose; Benzimidazoles; Chromatography; Lansoprazole; Models, Chemical; Omeprazole; Pantoprazole; Pressure; Rabeprazole; Stereoisomerism; Sulfoxides; Temperature; Time Factors

2004
Pachydermia is not diagnostic of active laryngopharyngeal reflux disease.
    The Laryngoscope, 2004, Volume: 114, Issue:9

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Benzimidazoles; Drug Therapy, Combination; Female; Gastric Acidity Determination; Gastroesophageal Reflux; Humans; Hypertrophy; Lansoprazole; Laryngeal Diseases; Laryngeal Mucosa; Laryngoscopy; Long-Term Care; Male; Middle Aged; Omeprazole; Pantoprazole; Pharyngeal Diseases; Proton Pump Inhibitors; Retrospective Studies; Sulfoxides; Treatment Outcome; Voice Disorders

2004
[Choice of proton pump inhibitors--does it play any role?].
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2004, Oct-21, Volume: 124, Issue:20

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Dose-Response Relationship, Drug; Drugs, Generic; Humans; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Sulfoxides

2004
Results of triple eradication therapy in Japanese children: a retrospective multicenter study.
    Journal of gastroenterology, 2004, Volume: 39, Issue:9

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles; Child; Child, Preschool; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Humans; Infant; Lansoprazole; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Retrospective Studies; Sulfoxides

2004
Cost effective prescribing of proton pump inhibitors (PPI's) in the GMS Scheme.
    Irish medical journal, 2005, Volume: 98, Issue:3

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Community Pharmacy Services; Cost-Benefit Analysis; Drug Costs; Enzyme Inhibitors; Health Care Surveys; Humans; Ireland; Lansoprazole; National Health Programs; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Sulfoxides

2005
Cost-effectiveness comparison of current proton-pump inhibitors to treat gastro-oesophageal reflux disease in the UK.
    Current medical research and opinion, 2005, Volume: 21, Issue:10

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Esomeprazole; Gastroesophageal Reflux; Humans; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Sulfoxides; United Kingdom

2005
Hydroxyl radical scavenging reactivity of proton pump inhibitors.
    Biochemical pharmacology, 2006, Apr-28, Volume: 71, Issue:9

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Benzimidazoles; Cattle; Copper Sulfate; Deoxyribose; Enzyme Inhibitors; Erythrocytes; Free Radical Scavengers; Heme; Hyaluronic Acid; Hydroxyl Radical; Iron Compounds; Lansoprazole; Omeprazole; Pantoprazole; Proton Pumps; Sulfides; Sulfoxides

2006
A therapeutic substitution policy for proton pump inhibitors: clinical and economic consequences.
    Clinical pharmacology and therapeutics, 2006, Volume: 79, Issue:4

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Anti-Ulcer Agents; Benzimidazoles; British Columbia; Cost Savings; Databases, Factual; Drug Utilization Review; Female; Health Services for the Aged; Hospitalization; Humans; Insurance, Pharmaceutical Services; Lansoprazole; Male; Omeprazole; Pantoprazole; Practice Patterns, Physicians'; Rabeprazole; Sulfoxides

2006
Sub-optimal proton pump inhibitor dosing is prevalent in patients with poorly controlled gastro-oesophageal reflux disease.
    Alimentary pharmacology & therapeutics, 2006, May-15, Volume: 23, Issue:10

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Drug Administration Schedule; Enzyme Inhibitors; Female; Gastroesophageal Reflux; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Sulfoxides; Time Factors

2006
Reversed-phase high performance liquid chromatographic method for the determination of lansoprazole, omeprazole and pantoprazole sodium sesquihydrate in presence of their Acid-induced degradation products.
    Chemical & pharmaceutical bulletin, 2006, Volume: 54, Issue:6

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acids; Anti-Ulcer Agents; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Drug Stability; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors

2006
Effect of proton pump inhibitors on hepatic regeneration.
    European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes, 2006, Volume: 38, Issue:3

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Benzimidazoles; Enzyme Inhibitors; Female; Hepatectomy; Ki-67 Antigen; Lansoprazole; Liver; Liver Regeneration; Male; Omeprazole; Organ Size; Pantoprazole; Proton Pump Inhibitors; Rats; Rats, Wistar; Sulfoxides

2006
An in vitro investigation on acid catalyzed reactions of proton pump inhibitors in the absence of an electrophile.
    International journal of pharmaceutics, 2006, Oct-12, Volume: 323, Issue:1-2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acids; Anti-Ulcer Agents; Catalysis; Dimerization; Drug Stability; Electrochemistry; Enzyme Inhibitors; Hydrogen-Ion Concentration; Lansoprazole; Omeprazole; Pantoprazole; Polarography; Proton Pump Inhibitors

2006
Preparative chiral chromatography and chiroptical characterization of enantiomers of omeprazole and related benzimidazoles.
    Chirality, 2007, Volume: 19, Issue:9

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Chromatography; Chromatography, Supercritical Fluid; Circular Dichroism; Enzyme Inhibitors; Lansoprazole; Models, Chemical; Molecular Conformation; Molecular Structure; Omeprazole; Pantoprazole; Rabeprazole; Stereoisomerism

2007
Pattern of proton pump inhibitor calls to Texas poison centers, 1998-2004.
    Journal of toxicology and environmental health. Part A, 2007, Apr-15, Volume: 70, Issue:8

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Animals; Child; Child, Preschool; Enzyme Inhibitors; Female; Humans; Lansoprazole; Male; Omeprazole; Pantoprazole; Poison Control Centers; Poisoning; Proton Pump Inhibitors; Rabeprazole; Retrospective Studies; Texas

2007
Long-term proton pump inhibitor use in children: a retrospective review of safety.
    Digestive diseases and sciences, 2008, Volume: 53, Issue:2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Child; Child, Preschool; Esophagitis; Female; Gastrins; Humans; Lansoprazole; Liver Function Tests; Male; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Retrospective Studies; Vitamin B 12

2008
Subacute cutaneous lupus erythematosus induced or exacerbated by proton pump inhibitors.
    Acta dermato-venereologica, 2008, Volume: 88, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Autoantibodies; Duodenal Ulcer; Esophagitis; Female; Humans; Lansoprazole; Lupus Erythematosus, Cutaneous; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Skin

2008
[Drug treatment and surgical indications in gastroesophageal reflux].
    Revista de gastroenterologia de Mexico, 2007, Volume: 72 Suppl 2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Clinical Trials as Topic; Fundoplication; Gastroesophageal Reflux; Histamine Antagonists; Humans; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Time Factors

2007
Semipreparative chiral supercritical fluid chromatography in the fractionation of lansoprazole and two related antiulcer drugs enantiomers.
    Journal of separation science, 2008, Volume: 31, Issue:8

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Chemical Fractionation; Chemistry Techniques, Analytical; Chemistry, Pharmaceutical; Chromatography; Chromatography, Supercritical Fluid; Equipment Design; Lansoprazole; Models, Chemical; Pantoprazole; Pharmaceutical Preparations; Rabeprazole; Stereoisomerism; Time Factors

2008
[General practitioners' management of gastroesophageal reflux in France in 2005: a pharmacoeconomic study].
    Presse medicale (Paris, France : 1983), 2008, Volume: 37, Issue:10

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Costs and Cost Analysis; Esomeprazole; Family Practice; Female; France; Gastroesophageal Reflux; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pumps; Rabeprazole

2008
Omeprazole, lansoprazole and pantoprazole had no effect on blood pressure and electrocardiogram of anesthetized rat.
    Pharmacological research, 2008, Volume: 58, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anesthesia; Animals; Blood Pressure; Dose-Response Relationship, Drug; Electric Stimulation; Electrocardiography; Female; Heart Atria; Heart Rate; Humans; In Vitro Techniques; Injections, Intravenous; Lansoprazole; Male; Myocardial Contraction; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rats; Rats, Wistar

2008
[Comparison of Helicobacter pylori eradication rate in patients with non-ulcer dyspepsia and peptic ulcer diseases according to proton pump inhibitors].
    The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2008, Volume: 52, Issue:2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Data Interpretation, Statistical; Drug Therapy, Combination; Dyspepsia; Enzyme Inhibitors; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pantoprazole; Peptic Ulcer; Proton Pump Inhibitors; Rabeprazole

2008
Simultaneous estimation of four proton pump inhibitors--lansoprazole, omeprazole, pantoprazole and rabeprazole: development of a novel generic HPLC-UV method and its application to clinical pharmacokinetic study.
    Biomedical chromatography : BMC, 2009, Volume: 23, Issue:7

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Chromatography, High Pressure Liquid; Drug Stability; Humans; Isoxazoles; Lansoprazole; Male; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Zonisamide

2009
[13C]-pantoprazole breath test to predict CYP2C19 phenotype and efficacy of a proton pump inhibitor, lansoprazole.
    Alimentary pharmacology & therapeutics, 2009, Volume: 30, Issue:3

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Breath Tests; Cytochrome P-450 CYP2C19; Enzyme Inhibitors; Female; Humans; Lansoprazole; Male; Middle Aged; Pantoprazole; Proton Pump Inhibitors; Young Adult

2009
Novel approaches to inhibition of gastric acid secretion.
    Current gastroenterology reports, 2010, Volume: 12, Issue:6

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Enzyme Inhibitors; Gastric Acid; Gastroesophageal Reflux; Histamine Antagonists; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Ranitidine

2010
Direct injection of native aqueous matrices by achiral-chiral chromatography ion trap mass spectrometry for simultaneous quantification of pantoprazole and lansoprazole enantiomers fractions.
    Journal of chromatography. A, 2011, May-20, Volume: 1218, Issue:20

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Humic Substances; Lansoprazole; Least-Squares Analysis; Pantoprazole; Reproducibility of Results; Rivers; Sensitivity and Specificity; Serum Albumin, Bovine; Stereoisomerism; Tandem Mass Spectrometry; Water Pollutants, Chemical

2011
The proton pump inhibitor, omeprazole, but not lansoprazole or pantoprazole, is a metabolism-dependent inhibitor of CYP2C19: implications for coadministration with clopidogrel.
    Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:11

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Clopidogrel; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9; Drug Interactions; Enzyme Inhibitors; Esomeprazole; Hepatocytes; Humans; Inhibitory Concentration 50; Lansoprazole; Microsomes; Microsomes, Liver; Omeprazole; Pantoprazole; Protein Binding; Proton Pump Inhibitors; Recombinant Proteins; Ticlopidine

2011
Proton pump inhibitors omeprazole, lansoprazole and pantoprazole induce relaxation in the rat lower oesophageal sphincter.
    The Journal of pharmacy and pharmacology, 2011, Volume: 63, Issue:10

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Angiotensins; Animals; Carbachol; Electric Stimulation; Esophageal Sphincter, Lower; Gastroesophageal Reflux; Lansoprazole; Muscle Relaxation; Muscle, Smooth; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rats; Rats, Wistar

2011
In vitro evaluation of phototoxic properties of proton pump inhibitors, H2-receptor antagonists and statins.
    Acta dermato-venereologica, 2012, Volume: 92, Issue:2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Ascorbic Acid; Cimetidine; Erythrocytes; Famotidine; Hemolysis; Histamine H2 Antagonists; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lansoprazole; Lovastatin; Nizatidine; Omeprazole; Pantoprazole; Pravastatin; Proton Pump Inhibitors; Ranitidine; Ultraviolet Rays

2012
Evaluation of six proton pump inhibitors as inhibitors of various human cytochromes P450: focus on cytochrome P450 2C19.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:9

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aryl Hydrocarbon Hydroxylases; Biotransformation; Cells, Cultured; Computer Simulation; Cytochrome P-450 CYP2C19; Dealkylation; Dexlansoprazole; Diazepam; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Esomeprazole; Hepatocytes; Humans; Kinetics; Lansoprazole; Liver; Microsomes, Liver; Models, Biological; NADP; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Recombinant Proteins; Substrate Specificity

2012
[Factors affecting efficacy of gastroesophageal reflux disease treatment with proton pump inhibitors].
    Terapevticheskii arkhiv, 2012, Volume: 84, Issue:2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Female; Gastroesophageal Reflux; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Treatment Outcome

2012
Cutaneous reactions to proton pump inhibitors: a case-control study.
    Journal of drugs in dermatology : JDD, 2012, Volume: 11, Issue:10

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Angioedema; Case-Control Studies; Chi-Square Distribution; Drug Eruptions; Esomeprazole; Exanthema; Female; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pantoprazole; Prevalence; Proton Pump Inhibitors; Rabeprazole; Retrospective Studies; Statistics, Nonparametric; Stevens-Johnson Syndrome; Thailand; Urticaria; Young Adult

2012
Risk of adverse cardiovascular outcomes and all-cause mortality associated with concomitant use of clopidogrel and proton pump inhibitors in elderly patients.
    Current medical research and opinion, 2013, Volume: 29, Issue:4

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Case-Control Studies; Clopidogrel; Cohort Studies; Coronary Artery Bypass; Drug Interactions; Drug Therapy, Combination; Esomeprazole; Female; Humans; Lansoprazole; Male; Myocardial Infarction; Omeprazole; Pantoprazole; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Rabeprazole; Risk; Stroke; Ticlopidine

2013
Inhibition of lysosomal enzyme activities by proton pump inhibitors.
    Journal of gastroenterology, 2013, Volume: 48, Issue:12

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Cell Line; Cell Line, Tumor; Dose-Response Relationship, Drug; Enzymes; Humans; Hydrogen-Ion Concentration; Immune System; Immunotherapy; Lansoprazole; Lysosomes; Male; Mass Spectrometry; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Omeprazole; Pantoprazole; Prodrugs; Proton Pump Inhibitors; Spleen

2013
Normal and polar-organic-phase high-performance liquid chromatographic enantioresolution of omeprazole, rabeprazole, lansoprazole and pantoprazole using monochloro-methylated cellulose-based chiral stationary phase and determination of dexrabeprazole.
    Biomedical chromatography : BMC, 2014, Volume: 28, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Chromatography, High Pressure Liquid; Lansoprazole; Omeprazole; Pantoprazole; Rabeprazole; Stereoisomerism

2014
Patterns of proton pump inhibitor utilization in gastroesophageal reflux disease and the effect of restrictions on reimbursement: a nationwide prescription database study.
    Scandinavian journal of gastroenterology, 2013, Volume: 48, Issue:9

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Drug Substitution; Esomeprazole; Gastroesophageal Reflux; Health Policy; Humans; Insurance, Health, Reimbursement; Lansoprazole; Norway; Omeprazole; Pantoprazole; Proton Pump Inhibitors

2013
Reaction of proton pump inhibitors with model peptides results in novel products.
    Journal of pharmacological sciences, 2013, Volume: 122, Issue:3

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Catalytic Domain; Cysteine; Enzyme Inhibitors; H(+)-K(+)-Exchanging ATPase; Hydrogen-Ion Concentration; Lansoprazole; Mass Spectrometry; Molecular Structure; Omeprazole; Pantoprazole; Peptides; Proton Pump Inhibitors; Pyridones; Sulfamerazine

2013
Slow, spontaneous degradation of lansoprazole, omeprazole and pantoprazole tablets: isolation and structural characterization of the toxic antioxidants 3H-benzimidazole-2-thiones.
    Die Pharmazie, 2013, Volume: 68, Issue:9

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Antioxidants; Benzimidazoles; Chromatography, High Pressure Liquid; Drug Stability; Indicators and Reagents; Lansoprazole; Magnetic Resonance Spectroscopy; Omeprazole; Pantoprazole; Spectrometry, Mass, Electrospray Ionization; Tablets; Temperature; Thiones

2013
Relaxant effect of proton pump inhibitors on in vitro myometrium from pregnant women.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2014, Feb-14, Volume: 52

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Apamin; Calcium; Dinoprostone; Esomeprazole; Female; Humans; In Vitro Techniques; Indomethacin; Lansoprazole; Muscle Contraction; Myometrium; NG-Nitroarginine Methyl Ester; Omeprazole; Oxytocin; Pantoprazole; Peptides; Potassium Chloride; Pregnancy; Proton Pump Inhibitors; Rabeprazole; Tocolytic Agents

2014
The stereoselectivity of CYP2C19 on R- and S-isomers of proton pump inhibitors.
    Chemical biology & drug design, 2014, Volume: 83, Issue:5

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Binding Sites; Cytochrome P-450 CYP2C19; Lansoprazole; Molecular Conformation; Molecular Dynamics Simulation; Omeprazole; Pantoprazole; Protein Binding; Protein Structure, Tertiary; Proton Pump Inhibitors; Stereoisomerism; Thermodynamics

2014
Comparative risk of ischemic stroke among users of clopidogrel together with individual proton pump inhibitors.
    Stroke, 2015, Volume: 46, Issue:3

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Brain Ischemia; Clopidogrel; Data Interpretation, Statistical; Drug Therapy, Combination; Esomeprazole; Female; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pantoprazole; Proportional Hazards Models; Proton Pump Inhibitors; Rabeprazole; Retrospective Studies; Risk; Stroke; Ticlopidine

2015
In vitro study of the variable effects of proton pump inhibitors on voriconazole.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:9

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Antifungal Agents; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Drug Interactions; Esomeprazole; Humans; Lansoprazole; Microsomes, Liver; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Voriconazole

2015
Lansoprazole is an antituberculous prodrug targeting cytochrome bc1.
    Nature communications, 2015, Jul-09, Volume: 6

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Antitubercular Agents; Cell Line; Drug Discovery; Drug Resistance, Bacterial; Electron Transport Complex III; Fibroblasts; High-Throughput Screening Assays; Humans; Lansoprazole; Macrophages; Mice; Mycobacterium tuberculosis; Omeprazole; Pantoprazole; Prodrugs; Proton Pump Inhibitors; Sulfides; Tuberculosis, Multidrug-Resistant

2015
Negative Effect of Proton-pump Inhibitors (PPIs) on Helicobacter pylori Growth, Morphology, and Urease Test and Recovery after PPI Removal--An In vitro Study.
    Helicobacter, 2016, Volume: 21, Issue:2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Bacterial Agents; Female; Helicobacter pylori; Humans; Lansoprazole; Male; Microbial Sensitivity Tests; Microbial Viability; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Urease; Young Adult

2016
Medical and non-medical predictors of initiating long-term use of proton pump inhibitors: a nationwide cohort study of first-time users during a 10-year period.
    Alimentary pharmacology & therapeutics, 2016, Volume: 44, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Cohort Studies; Esomeprazole; Female; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Young Adult

2016
Proton Pump Inhibitors Increase Risk for Hepatic Encephalopathy in Patients With Cirrhosis in A Population Study.
    Gastroenterology, 2017, Volume: 152, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administrative Claims, Healthcare; Adult; Aged; Case-Control Studies; Esomeprazole; Female; Hepatic Encephalopathy; Humans; Incidence; Insurance, Health; Lansoprazole; Liver Cirrhosis; Longitudinal Studies; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Taiwan

2017
Empirical treatment of outpatients with gastroesophageal reflux disease with proton pump inhibitors: A survey of Chinese patients (the ENLIGHT Study).
    Journal of gastroenterology and hepatology, 2018, Volume: 33, Issue:10

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Asian People; Esomeprazole; Female; Gastroesophageal Reflux; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Outpatients; Pantoprazole; Prospective Studies; Proton Pump Inhibitors; Rabeprazole; Time Factors; Treatment Outcome; Young Adult

2018
Associations of proton pump inhibitors and hospitalization due to hyponatremia: A population-based case-control study.
    European journal of internal medicine, 2019, Volume: 59

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Esomeprazole; Female; Hospitalization; Humans; Hyponatremia; Lansoprazole; Logistic Models; Male; Middle Aged; Multivariate Analysis; Omeprazole; Pantoprazole; Population; Proton Pump Inhibitors; Rabeprazole; Retrospective Studies; Sweden; Young Adult

2019
The status of proton pump inhibitor use: a prescription survey of 45 hospitals in China.
    Revista espanola de enfermedades digestivas, 2019, Volume: 111, Issue:10

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; China; Comorbidity; Esomeprazole; Female; Health Care Surveys; Hospitals; Humans; Inappropriate Prescribing; Lansoprazole; Male; Middle Aged; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Young Adult

2019
Comparison of the gastric acid inhibition function among lansoprazole, pantoprazole, and their respective stereoisomers in healthy Chinese subjects
.
    International journal of clinical pharmacology and therapeutics, 2019, Volume: 57, Issue:11

    Topics: Anti-Ulcer Agents; Gastric Acidity Determination; Healthy Volunteers; Humans; Hydrogen-Ion Concentration; Lansoprazole; Pantoprazole; Stereoisomerism

2019
Qualimetric analysis of proton pump inhibitors in Ukraine.
    Wiadomosci lekarskie (Warsaw, Poland : 1960), 2019, Volume: 72, Issue:9 cz 2

    Topics: Dexlansoprazole; Esomeprazole; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Quality Control; Rabeprazole; Ukraine

2019
Proton Pump Inhibitor-Treated H. pylori Adjust Cell Envelope Fatty Acid and Cholesterol Content to Survive.
    Archives of Iranian medicine, 2020, 01-01, Volume: 23, Issue:1

    Topics: Cell Membrane; Cholesterol; Fatty Acids; Helicobacter pylori; Lansoprazole; Microbial Sensitivity Tests; Microbial Viability; Pantoprazole; Proton Pump Inhibitors

2020
Inhibition of monoglyceride lipase by proton pump inhibitors: investigation using docking and in vitro experiments.
    Pharmacological reports : PR, 2020, Volume: 72, Issue:2

    Topics: Humans; Lansoprazole; Molecular Docking Simulation; Molecular Structure; Monoacylglycerol Lipases; Pantoprazole; Protein Binding; Proton Pump Inhibitors; Rabeprazole; Substrate Specificity

2020
Effect of proton pump inhibitors on voriconazole concentrations in Chinese patients with malignant hematological diseases.
    European journal of clinical pharmacology, 2020, Volume: 76, Issue:6

    Topics: Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Drug Interactions; Female; Humans; Lansoprazole; Male; Molecular Docking Simulation; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Retrospective Studies; Voriconazole

2020
Comparison of Antioxidant Effects of the Proton Pump-Inhibiting Drugs Omeprazole, Esomeprazole, Lansoprazole, Pantoprazole, and Rabeprazole.
    Pharmacology, 2020, Volume: 105, Issue:11-12

    Topics: Antioxidants; Ascorbic Acid; Biphenyl Compounds; Esomeprazole; Free Radicals; In Vitro Techniques; Inhibitory Concentration 50; Lansoprazole; Omeprazole; Pantoprazole; Picrates; Proton Pump Inhibitors; Rabeprazole; Spectrophotometry

2020
Simultaneous enantioselective determination of omeprazole, rabeprazole, lansoprazole, and pantoprazole enantiomers in human plasma by chiral liquid chromatography-tandem mass spectrometry.
    Journal of separation science, 2020, Volume: 43, Issue:16

    Topics: Chromatography, High Pressure Liquid; Humans; Lansoprazole; Molecular Structure; Omeprazole; Pantoprazole; Rabeprazole; Stereoisomerism; Tandem Mass Spectrometry

2020
Pantoprazole, a proton-pump inhibitor, impairs human sperm motility and capacitation in vitro.
    Andrology, 2020, Volume: 8, Issue:6

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Fertilization; Humans; Lansoprazole; Male; Membrane Potentials; Middle Aged; Omeprazole; Pantoprazole; Phosphorylation; Proton Pump Inhibitors; Rabeprazole; Retrospective Studies; Semen Analysis; Sperm Capacitation; Sperm Maturation; Sperm Motility; Spermatozoa; Young Adult

2020
Spectroscopic study of in situ-formed metallocomplexes of proton pump inhibitors in water.
    Chemical biology & drug design, 2021, Volume: 97, Issue:2

    Topics: Coordination Complexes; Ferric Compounds; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Spectrophotometry; Transition Elements; Water

2021
Simultaneous Quantitative Analysis of Six Proton-Pump Inhibitors with a Single Marker and Evaluation of Stability of Investigated Drugs in Polypropylene Syringes for Continuous Infusion Use.
    Drug design, development and therapy, 2020, Volume: 14

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Chromatography, High Pressure Liquid; Drugs, Investigational; Esomeprazole; Humans; Lansoprazole; Molecular Structure; Omeprazole; Pantoprazole; Polypropylenes; Proton Pump Inhibitors; Rabeprazole

2020
Pantoprazole-induced Thrombocytopenia: Unresponsive to Corticosteroid and Thrombocyte Concentrate Transfusion.
    Journal of pharmacy practice, 2023, Volume: 36, Issue:3

    Topics: Blood Platelets; Humans; Lansoprazole; Male; Middle Aged; Pantoprazole; Proton Pump Inhibitors; Thrombocytopenia

2023
Proton pump inhibitor therapy and risk of knee replacement surgery: a general population-based cohort study.
    Osteoarthritis and cartilage, 2022, Volume: 30, Issue:4

    Topics: Cohort Studies; Esomeprazole; Humans; Lansoprazole; Omeprazole; Osteoarthritis, Knee; Pantoprazole; Proton Pump Inhibitors; Rabeprazole

2022
Acid suppressants use and risk of atherosclerotic cardiovascular disease in middle-aged and older adults.
    Atherosclerosis, 2022, Volume: 358

    Topics: Aged; Antihypertensive Agents; Atherosclerosis; Cardiovascular Diseases; Histamine; Humans; Lansoprazole; Middle Aged; Omeprazole; Pantoprazole; Prospective Studies; Proton Pump Inhibitors; Risk Assessment; Risk Factors

2022
Proton pump inhibitor-induced risk of chronic kidney disease is associated with increase of indoxyl sulfate synthesis via inhibition of CYP2E1 protein degradation.
    Chemico-biological interactions, 2022, Dec-01, Volume: 368

    Topics: Animals; Cytochrome P-450 CYP2E1; Indican; Lansoprazole; Mice; Omeprazole; Pantoprazole; Proteolysis; Proton Pump Inhibitors; Renal Insufficiency, Chronic; Uremic Toxins

2022